
Lsp 12.5mg Injection
Marketer
Arvincare Pharma
Salt Composition
Levosulpiride (12.5mg)
Overview Lsp 12.5mg Injection
LSP 12.5mg Injection is prescribed for various gastrointestinal issues, including functional dyspepsia, nausea, vomiting, and diabetic gastroparesis. Its mechanism of action facilitates improved digestive motility and addresses stomach and intestinal disorders. Administered orally, this injection may be taken with or without food; however, consistent daily timing ensures optimal therapeutic levels. Follow your physician's instructions precisely regarding dosage and duration. If a dose is missed, take it as soon as recalled. Commonly reported side effects include headache and tiredness. Drowsiness and dizziness are also possible; therefore, avoid driving or activities demanding concentration until the effects are known. Seek immediate medical attention if you experience amenorrhea, galactorrhea, altered libido, or fever following medication intake.
Uses of Lsp 12.5mg Injection
Managing nausea and vomiting | Addressing functional dyspepsia | Diabetic gastroparesis management (diabetic neuropathy impacting gastric motility) | Treating nausea-related symptoms
Major Benefits of Lsp 12.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Lsp 12.5mg Injection:
- Menstrual disorder
- Breast enlargement in male
- Increased libido
- Increased prolactin level in blood
- Extrapyramidal symptoms
- Weight gain
- Akathisia (inability to stay still)
- Increased liver enzymes
- Constipation
- Insomnia (difficulty in sleeping)
- Sedation
- Maculopapular rash
- Sleepiness
- Vertigo
How to use Lsp 12.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lsp 12.5mg Injection works:
LSP 12.5mg Injection, an atypical antipsychotic medication, enhances acetylcholine release, a key neurotransmitter. This boosts gastrointestinal motility, thereby counteracting reflux and alleviating nausea and vomiting. Its modulation of gastrointestinal motor activity also facilitates improved gastric emptying.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Lsp 12.5mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering 12.5mg Lsp Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Lsp 12.5mg Injection while breastfeeding is likely inadvisable. Available data from human studies indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
The 12.5mg Lsp Injection can induce adverse reactions that may impair driving ability. Drowsiness is a potential side effect of 12.5mg Lsp Injection; therefore, avoid driving or activities demanding concentration until the drug's effects are understood.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lsp 12.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lsp 12.5mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Lsp 12.5mg Injection :
Omit a dose of Lsp 12.5mg Injection? Seek medical advice immediately.
Facts to Know About Lsp 12.5mg Injection
| Label | Value |
|---|---|
| Type of Compound | Sulfonanilide compound |
| Potential for Dependence | None. |
| Treatment Category | Central and peripheral nervous system |
